6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide

C41H65N9O5 — CID 166683565

IUPAC6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide
SMILESCC(=O)N1CC(Nc2cc(C(=O)NCC(O)CN3CCC4C(CCC(OCc5ocnc5C)N4C4CCCCCCCCC4)C3)nc(N3CCCCC3)n2)C1
InChIInChI=1S/C41H65N9O5/c1-29-37(55-28-43-29)27-54-39-16-15-31-23-47(20-17-36(31)50(39)33-13-9-6-4-3-5-7-10-14-33)26-34(52)22-42-40(53)35-21-38(44-32-24-49(25-32)30(2)51)46-41(45-35)48-18-11-8-12-19-48/h21,28,31-34,36,39,52H,3-20,22-27H2,1-2H3,(H,42,53)(H,44,45,46)
InChIKeyIDNORXVBDHWBBB-UHFFFAOYSA-N
MW764.03 g/mol
LogP4.72
Rot. Bonds12

About 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide

6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide (PubChem CID 166683565) has the molecular formula C41H65N9O5 and a molecular weight of 764.03 g/mol. Its IUPAC name is 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide.

Molecular Properties

Compound Name6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide
PubChem CID166683565
Molecular FormulaC41H65N9O5
Molecular Weight764.03 g/mol
Exact Mass763.51
IUPAC Name6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide
SMILESCC(=O)N1CC(Nc2cc(C(=O)NCC(O)CN3CCC4C(CCC(OCc5ocnc5C)N4C4CCCCCCCCC4)C3)nc(N3CCCCC3)n2)C1
InChIInChI=1S/C41H65N9O5/c1-29-37(55-28-43-29)27-54-39-16-15-31-23-47(20-17-36(31)50(39)33-13-9-6-4-3-5-7-10-14-33)26-34(52)22-42-40(53)35-21-38(44-32-24-49(25-32)30(2)51)46-41(45-35)48-18-11-8-12-19-48/h21,28,31-34,36,39,52H,3-20,22-27H2,1-2H3,(H,42,53)(H,44,45,46)
InChIKeyIDNORXVBDHWBBB-UHFFFAOYSA-N
XLogP4.72
TPSA152.43 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds12
Heavy Atoms55
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500764.03
LogP ≤ 54.72
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Analyze 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide?
The IUPAC name of 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide (CID 166683565) is 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide.
What is the SMILES notation for 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide?
The canonical SMILES for 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide is CC(=O)N1CC(Nc2cc(C(=O)NCC(O)CN3CCC4C(CCC(OCc5ocnc5C)N4C4CCCCCCCCC4)C3)nc(N3CCCCC3)n2)C1.
What is the InChIKey of 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide?
The InChIKey is IDNORXVBDHWBBB-UHFFFAOYSA-N. The full InChI is InChI=1S/C41H65N9O5/c1-29-37(55-28-43-29)27-54-39-16-15-31-23-47(20-17-36(31)50(39)33-13-9-6-4-3-5-7-10-14-33)26-34(52)22-42-40(53)35-21-38(44-32-24-49(25-32)30(2)51)46-41(45-35)48-18-11-8-12-19-48/h21,28,31-34,36,39,52H,3-20,22-27H2,1-2H3,(H,42,53)(H,44,45,46).
What are the key properties of 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide?
6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide has a molecular weight of 764.03 g/mol, XLogP of 4.72, 12 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[(1-acetylazetidin-3-yl)amino]-N-[3-[1-cyclodecyl-2-[(4-methyl-1,3-oxazol-5-yl)methoxy]-2,3,4,4a,5,7,8,8a-octahydro-1,6-naphthyridin-6-yl]-2-hydroxypropyl]-2-piperidin-1-ylpyrimidine-4-carboxamide is sourced from PubChem (CID 166683565), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).